{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T21:33:30Z","timestamp":1769895210193,"version":"3.49.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Gujarat State Biotechnology Mission, Government of Gujarat, India","award":["GSBTM\/JD(R&D)\/618\/21-22\/1223"],"award-info":[{"award-number":["GSBTM\/JD(R&D)\/618\/21-22\/1223"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Genet Genomics"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s00438-026-02349-8","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T08:29:47Z","timestamp":1769848187000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cell-free DNA in chemical carcinogen induced mouse lung cancer and colon cancer model: its implications in diagnostics and therapeutics"],"prefix":"10.1007","volume":"301","author":[{"given":"Devangkumar D.","family":"Trivedi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aafrinbanu M.","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saumya K.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarat Kumar","family":"Dalai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1755-3352","authenticated-orcid":false,"given":"Sonal R.","family":"Bakshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,31]]},"reference":[{"key":"2349_CR1","first-page":"365","volume":"104","author":"P Anandakumar","year":"2009","unstructured":"Anandakumar P, Kamaraj S, Ramakrishnan G, Jagan S, Devaki TJB (2009) Chemopreventive task of capsaicin against benzo (a) pyrene-induced lung cancer in Swiss albino mice. Pharmacol C Toxicol 104:365","journal-title":"Pharmacol C Toxicol"},{"key":"2349_CR2","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nrc3944","volume":"15","author":"S Aparicio","year":"2015","unstructured":"Aparicio S, Hidalgo M, Kung ALJNRC (2015) Examining the utility of patient-derived xenograft mouse models. Nat Rev Cancer 15:311\u2013316","journal-title":"Nat Rev Cancer"},{"key":"2349_CR3","first-page":"30","volume":"9","author":"V Bantal","year":"2018","unstructured":"Bantal V, Ghanta P, Tejasvi PJP (2018a) Piperine presents chemo-preventive property against 1, 2-Dimethyl Hydrazine induced colon cancer in mice: biochemical and physiological evidences. Pharmacologia 9:30\u201338","journal-title":"Pharmacologia"},{"key":"2349_CR4","unstructured":"Bantal V, Ghanta P, Tejasvi PJP (2018b) Piperine presents chemo-preventive property against 1, 2-Dimethyl hydrazine induced colon cancer in mice: biochemical and physiological evidences. 9:30\u201338"},{"key":"2349_CR5","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.cbi.2015.10.020","volume":"242","author":"LN Bodduluru","year":"2015","unstructured":"Bodduluru LN, Kasala ER, Barua CC, Karnam KC, Dahiya V, Ellutla MJC-bi (2015) Antiproliferative and antioxidant potential of hesperetin against benzo (a) pyrene-induced lung carcinogenesis in Swiss albino mice. Chem Biological Interact 242:345\u2013352","journal-title":"Chem Biological Interact"},{"key":"2349_CR6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal AJ (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin 74:229\u2013263","journal-title":"Cancer J Clin"},{"key":"2349_CR7","first-page":"4171","volume":"6","author":"RB Capone","year":"2000","unstructured":"Capone RB, Pai SI, Koch WM, Gillison ML, Danish HN, Westra WH, Daniel R, Shah KV, Sidransky DJC (2000) Detection and quantitation of human papillomavirus (HPV) DNA in the sera of patients with HPV-associated head and neck squamous cell carcinoma. Clin Cancer Res 6:4171\u20134175","journal-title":"Clin Cancer Res"},{"key":"2349_CR8","first-page":"1381","volume":"5","author":"P-W Chiang","year":"1999","unstructured":"Chiang P-W, Beer DG, Wei W-L, Orringer MB, Kurnit DMJC (1999) Detection of erbB-2 amplifications in tumors and sera from esophageal carcinoma patients. Clin Cancer Res 5:1381\u20131386","journal-title":"Clin Cancer Res"},{"key":"2349_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1752-0509-8-S4-S11","volume":"8","author":"C-H Chin","year":"2014","unstructured":"Chin C-H, Chen S-H, Wu HH, Ho CW, Ko M-T, Lin CY (2014) cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol 8:1\u20137","journal-title":"BMC Syst Biol"},{"key":"2349_CR10","first-page":"3646","volume":"62","author":"V Combaret","year":"2002","unstructured":"Combaret V, Audoynaud C, Iacono I, Favrot M-C, Schell M, Bergeron C, Puisieux AJC (2002) Circulating MYCN DNA as a tumor-specific marker in neuroblastoma patients. Cancer Res 62:3646\u20133648","journal-title":"Cancer Res"},{"key":"2349_CR11","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s40291-013-0062-3","volume":"18","author":"L Cunha","year":"2014","unstructured":"Cunha L, Horvath I, Ferreira S, Lemos J, Costa P, Vieira D, Veres DS, Szigeti K, Summavielle T (2014) Preclinical imaging: an essential ally in modern biosciences. Mol Diagnos Ther 18:153\u2013173","journal-title":"Mol Diagnos Ther"},{"key":"2349_CR12","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1200\/JCO.2012.45.2011","volume":"32","author":"LA Diaz Jr","year":"2014","unstructured":"Diaz LA Jr, Bardelli AJJ (2014) Liquid biopsies: genotyping circulating tumor DNA. J Clin Oncol 32:579","journal-title":"J Clin Oncol"},{"key":"2349_CR13","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1177\/0748233712440137","volume":"29","author":"T Ertekin","year":"2013","unstructured":"Ertekin T, Ekinci N, Karaca O, Nisari M, Canoz O, Ulger HJT, Health I (2013) Effect of angiostatin on 1, 2-dimethylhydrazine-induced colon cancer in mice. Toxicol Indus Health 29:490\u2013497","journal-title":"Toxicol Indus Health"},{"key":"2349_CR14","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.3747\/co.27.5223","volume":"27","author":"K Esfahani","year":"2020","unstructured":"Esfahani K, Roudaia L, Buhlaiga N, Del Rincon SV, Papneja N, Miller WH Jr. (2020) A review of cancer immunotherapy: from the past, to the present, to the future. Curr Oncol 27:S87\u2013s97","journal-title":"Curr Oncol"},{"key":"2349_CR15","first-page":"67","volume":"59","author":"M Esteller","year":"1999","unstructured":"Esteller M, Sanchez-Cespedes M, Rosell R, Sidransky D, Baylin SB, Herman JG (1999) Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res 59:67\u201370","journal-title":"Cancer Res"},{"key":"2349_CR16","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/ilar\/ily010","volume":"59","author":"K Gabrielson","year":"2018","unstructured":"Gabrielson K, Maronpot R, Monette S, Mlynarczyk C, Ramot Y, Nyska A, Sysa-Shah PJI (2018) In vivo imaging with confirmation by histopathology for increased rigor and reproducibility in translational research: A review of examples, options, and resources. ILAR J 59:80\u201398","journal-title":"ILAR J"},{"key":"2349_CR17","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/B978-0-12-821044-4.00007-8","volume-title":"Haschek and Rousseaux's Handbook of Toxicologic Pathology","author":"K Gabrielson","year":"2022","unstructured":"Gabrielson K, Sysa-Shah P, Lyons C, Artemov D, Foss CA, Winkelmann CT, Monette S (2022) In Vivo Small Animal Imaging: A Comparison to Gross and Histopathologic Observations in Animal Models. Haschek and Rousseaux\u2019s Handbook of Toxicologic Pathology. Elsevier, Amsterdam, pp 423\u2013457"},{"key":"2349_CR18","first-page":"1927","volume":"9","author":"WT Gunning","year":"2003","unstructured":"Gunning WT, Kramer PM, Lubet RA, Steele VE, End DW, Wouters W, Pereira MAJC (2003) Chemoprevention of benzo (a) pyrene-induced lung tumors in mice by the farnesyltransferase inhibitor R115777. Clin Cancer Res 9:1927\u20131930","journal-title":"Clin Cancer Res"},{"key":"2349_CR19","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/bjc.1973.183","volume":"28","author":"P Haase","year":"1973","unstructured":"Haase P, Cowen D, Knowles J, Cooper EJBJC (1973) Evaluation of dimethylhydrazine induced tumours in mice as a model system for colorectal cancer. Brit J Cancer 28:530\u2013543","journal-title":"Brit J Cancer"},{"key":"2349_CR20","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s43440-020-00138-7","volume":"72","author":"T Haider","year":"2020","unstructured":"Haider T, Pandey V, Banjare N, Gupta PN, Soni V (2020) Drug resistance in cancer: mechanisms and tackling strategies. Pharmacol Rep 72:1125\u20131151","journal-title":"Pharmacol Rep"},{"key":"2349_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"DJC Hanahan","year":"2022","unstructured":"Hanahan DJC (2022) Hallmarks of cancer: new dimensions. Cancer Discov 12:31\u201346","journal-title":"Cancer Discov"},{"key":"2349_CR22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RAJ (2000) The hallmarks of cancer. Cell 100:57\u201370","journal-title":"Cell"},{"key":"2349_CR23","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RAJ (2011) Hallmarks of cancer: the next generation. Cell 144:646\u2013674","journal-title":"Cell"},{"key":"2349_CR24","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.3390\/cancers6031769","volume":"6","author":"G Housman","year":"2014","unstructured":"Housman G, Byler S, Heerboth S, Lapinska K, Longacre M, Snyder N, Sarkar S (2014) Drug resistance in cancer: an overview. Cancers (Basel) 6:1769\u20131792","journal-title":"Cancers (Basel)"},{"key":"2349_CR25","doi-asserted-by":"publisher","first-page":"7125","DOI":"10.1016\/j.sjbs.2021.08.001","volume":"28","author":"X Hu","year":"2021","unstructured":"Hu X, Geetha RV, Surapaneni KM, Veeraraghavan VP, Chinnathambi A, Alahmadi TA, Manikandan V, Manokaran KJS (2021) Lung cancer induced by Benzo (A) Pyrene: ChemoProtective effect of sinapic acid in swiss albino mice. Saudi J Biol Sci 28:7125\u20137133","journal-title":"Saudi J Biol Sci"},{"key":"2349_CR26","first-page":"297","volume":"18","author":"M Ignatiadis","year":"2021","unstructured":"Ignatiadis M, Sledge GW, Jeffrey SS (2021) Liquid biopsy enters the clinic\u2014implementation issues and future challenges. Clin Oncol 18:297\u2013312","journal-title":"Clin Oncol"},{"key":"2349_CR27","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.biopha.2016.05.042","volume":"82","author":"ER Kasala","year":"2016","unstructured":"Kasala ER, Bodduluru LN, Barua CC, Gogoi RJB (2016a) Antioxidant and antitumor efficacy of Luteolin, a dietary flavone on benzo (a) pyrene-induced experimental lung carcinogenesis. Biomed Pharmacother 82:568\u2013577","journal-title":"Biomed Pharmacother"},{"key":"2349_CR28","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.pharep.2015.08.014","volume":"68","author":"ER Kasala","year":"2016","unstructured":"Kasala ER, Bodduluru LN, Barua CC, Madhana RM, Dahiya V, Budhani MK, Mallugari RR, Maramreddy SR, Gogoi RJ (2016b) Chemopreventive effect of chrysin, a dietary flavone against benzo (a) pyrene induced lung carcinogenesis in Swiss albino mice. Pharmacol Rep 68:310\u2013318","journal-title":"Pharmacol Rep"},{"key":"2349_CR29","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s00432-022-03923-4","volume":"148","author":"I Larionova","year":"2022","unstructured":"Larionova I, Rakina M, Ivanyuk E, Trushchuk Y, Chernyshova A, Denisov E (2022) Radiotherapy resistance: identifying universal biomarkers for various human cancers. J Cancer Res Clin Oncol 148:1015\u20131031","journal-title":"J Cancer Res Clin Oncol"},{"key":"2349_CR30","first-page":"465","volume":"51","author":"DT Lauber","year":"2017","unstructured":"Lauber DT, F\u00fcl\u00f6p A, Kov\u00e1cs T, Szigeti K, M\u00e1th\u00e9 D, Szij\u00e1rt\u00f3 AJL (2017) State of the art in vivo imaging techniques for laboratory animals. Laboratory Anim 51:465\u2013478","journal-title":"\u00a0Laboratory Anim"},{"key":"2349_CR31","first-page":"646","volume":"37","author":"S Leon","year":"1977","unstructured":"Leon S, Shapiro B, Sklaroff D, Yaros MJC (1977) Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 37:646\u2013650","journal-title":"Cancer Res"},{"key":"2349_CR32","first-page":"1409","volume":"17","author":"H Li","year":"2019","unstructured":"Li H, Jing C, Wu J, Ni J, Sha H, Xu X, Du Y, Lou R, Dong S, Feng JJO (2019) Circulating tumor DNA detection: A potential tool for colorectal cancer management. Oncol Lett 17:1409\u20131416","journal-title":"Oncol Lett"},{"key":"2349_CR33","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.2147\/CMAR.S302565","volume":"15","author":"Z Li","year":"2021","unstructured":"Li Z, Zheng W, Wang H, Cheng Y, Fang Y, Wu F, Sun G, Sun G, Lv C, Hui BJCM (2021) Application of animal models in cancer research: recent progress and future prospects. Cancer Manag Res 15:2455\u20132475","journal-title":"Cancer Manag Res"},{"key":"2349_CR34","first-page":"1188","volume":"59","author":"YD Lo","year":"1999","unstructured":"Lo YD, Chan LY, Lo K-W, Leung S-F, Zhang J, Chan AT, Lee JC, Hjelm NM, Johnson PJ, Huang DPJC (1999) Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. Cancer Res 59:1188\u20131191","journal-title":"\u00a0Cancer Res"},{"key":"2349_CR35","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/s41392-024-02021-w","volume":"9","author":"L Ma","year":"2024","unstructured":"Ma L, Guo H, Zhao Y, Liu Z, Wang C, Bu J, Sun T, Wei JJST, Therapy T (2024) Liquid biopsy in cancer current: status, challenges and future prospects. Signal Transduct Target Ther 9:336","journal-title":"Signal Transduct Target Ther"},{"key":"2349_CR36","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/clpt.2008.52","volume":"83","author":"D Mager","year":"2008","unstructured":"Mager D, Jusko WJCP (2008) Development of translational pharmacokinetic\u2013pharmacodynamic models. Clin Pharmacol Therap 83:909\u2013912","journal-title":"Clin Pharmacol Therap"},{"key":"2349_CR37","doi-asserted-by":"publisher","first-page":"16","DOI":"10.2133\/dmpk.24.16","volume":"24","author":"DE Mager","year":"2009","unstructured":"Mager DE, Woo S, Jusko WJ (2009) Scaling pharmacodynamics from in vitro and preclinical animal studies to humans. Drug Metabol Pharmacokinet 24:16\u201324","journal-title":"Drug Metabol Pharmacokinet"},{"key":"2349_CR38","doi-asserted-by":"publisher","first-page":"e93820","DOI":"10.1371\/journal.pone.0093820","volume":"9","author":"A Malhotra","year":"2014","unstructured":"Malhotra A, Nair P, Dhawan DKJP (2014) Study to evaluate molecular mechanics behind synergistic chemo-preventive effects of curcumin and resveratrol during lung carcinogenesis. PloS one 9:e93820","journal-title":"PloS one"},{"key":"2349_CR39","first-page":"241","volume":"142","author":"P Mandel","year":"1948","unstructured":"Mandel P (1948) Les acides nucleiques du plasma sanguin chez 1 homme. CR Seances Soc Biol Fil 142:241\u2013243","journal-title":"CR Seances Soc Biol Fil"},{"key":"2349_CR40","unstructured":"Mandel P, Metais PJJSB (1948) Comptes rendus des seances de la Societe de biologie et de ses filiales. 142:241\u2013243"},{"key":"2349_CR41","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.bionut.2014.08.009","volume":"4","author":"K Manigandan","year":"2014","unstructured":"Manigandan K, Jayaraj RL, Elangovan NJB, Nutrition P (2014) Taxifolin ameliorates 1, 2-dimethylhydrazine induced cell proliferation and redox avulsions in mice colon carcinogenesis. Biomed Prevent Nutr 4:499\u2013509","journal-title":"\u00a0Biomed Prevent Nutr"},{"key":"2349_CR42","doi-asserted-by":"publisher","first-page":"339","DOI":"10.15171\/apb.2017.041","volume":"7","author":"B Mansoori","year":"2017","unstructured":"Mansoori B, Mohammadi A, Davudian S, Shirjang S, Baradaran B (2017) The different mechanisms of cancer drug resistance: A brief review. Adv Pharm Bull 7:339\u2013348","journal-title":"Adv Pharm Bull"},{"key":"2349_CR43","first-page":"665","volume":"4","author":"A Mutirangura","year":"1998","unstructured":"Mutirangura A, Pornthanakasem W, Theamboonlers A, Sriuranpong V, Lertsanguansinchi P, Yenrudi S, Voravud N, Supiyaphun P, Poovorawan YJCAACR (1998) Epstein-Barr viral DNA in serum of patients with nasopharyngeal carcinoma. Clin Cancer Res 4:665\u2013669","journal-title":"Clin Cancer Res"},{"key":"2349_CR44","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1038\/nm0996-1035","volume":"2","author":"H Nawroz","year":"1996","unstructured":"Nawroz H, Koch W, Anker P, Stroun M, Sidransky DJN (1996) Microsatellite alterations in serum DNA of head and neck cancer patients. Nat Med 2:1035\u20131037","journal-title":"Nat Med"},{"key":"2349_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-022-01351-y","volume":"15","author":"M Nikanjam","year":"2022","unstructured":"Nikanjam M, Kato S, Kurzrock RJ (2022) Liquid biopsy: Current technology and clinical applications. J Hematol Oncol 15:1\u201314","journal-title":"J Hematol Oncol"},{"key":"2349_CR46","doi-asserted-by":"publisher","first-page":"660","DOI":"10.3390\/diagnostics10090660","volume":"10","author":"A Onaciu","year":"2020","unstructured":"Onaciu A, Munteanu R, Munteanu VC, Gulei D, Raduly L, Feder R-I, Pirlog R, Atanasov AG, Korban SS, Irimie AJD (2020) Spontaneous and induced animal models for cancer research. Diagnostics 10:660","journal-title":"Diagnostics"},{"key":"2349_CR47","doi-asserted-by":"publisher","first-page":"175883591879463","DOI":"10.1177\/1758835918794630","volume":"10","author":"R Palmirotta","year":"2018","unstructured":"Palmirotta R, Lovero D, Cafforio P, Felici C, Mannavola F, Pell\u00e8 E, Quaresmini D, Tucci M, Silvestris FJT (2018) Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology. Therap Adv Med Oncol 10:1758835918794630","journal-title":"Therap Adv Med Oncol"},{"key":"2349_CR48","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.31024\/ajpp.2019.5.6.15","volume":"5","author":"R Pemmireddy","year":"2019","unstructured":"Pemmireddy R, Alvala R, Sama V, Sriramoju AJAJP (2019) Effect of Ranolazine on 1, 2-Dimethyl hydrazine induced colon cancer in mice. Asian J Pharm Pharmacol 5:1183\u20131190","journal-title":"Asian J Pharm Pharmacol"},{"key":"2349_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-1-2","volume":"1","author":"W Pornthanakasem","year":"2001","unstructured":"Pornthanakasem W, Shotelersuk K, Termrungruanglert W, Voravud N, Niruthisard S, Mutirangura AJB (2001) Human papillomavirus DNA in plasma of patients with cervical cancer. BMC Cancer 1:1\u20138","journal-title":"BMC Cancer"},{"key":"2349_CR50","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/nm0996-1033","volume":"2","author":"X Qi Chen","year":"1996","unstructured":"Qi Chen X, Stroun M, Magnenat J-L, Nicod LP, Kurt A-M, Lyautey J, Lederrey C, Anker PJN (1996) Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat Med 2:1033\u20131035","journal-title":"Nat Med"},{"key":"2349_CR51","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.cell.2018.09.035","volume":"175","author":"MF Sanmamed","year":"2018","unstructured":"Sanmamed MF, Chen LJC (2018) A paradigm shift in cancer immunotherapy: from enhancement to normalization. Cell 175:313\u2013326","journal-title":"Cell"},{"key":"2349_CR52","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/nrc3066","volume":"11","author":"H Schwarzenbach","year":"2011","unstructured":"Schwarzenbach H, Hoon DS, Pantel KJNRC (2011) Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer 11:426\u2013437","journal-title":"Nat Rev Cancer"},{"key":"2349_CR53","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1038\/sj.bjc.6690495","volume":"80","author":"J Silva","year":"1999","unstructured":"Silva J, Dominguez G, Villanueva M, Gonzalez R, Garcia J, Corbacho C, Provencio M, Espana P, Bonilla FJB (1999) Aberrant DNA methylation of the p16INK4a gene in plasma DNA of breast cancer patients. Brit J Cancer 80:1262\u20131264","journal-title":"Brit J Cancer"},{"key":"2349_CR54","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/bioinformatics\/btq675","volume":"27","author":"ME Smoot","year":"2011","unstructured":"Smoot ME, Ono K, Ruscheinski J, Wang P-L, Ideker TJB (2011) Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 27:431\u2013432","journal-title":"Bioinformatics"},{"key":"2349_CR55","unstructured":"Sorenson GD, Pribish DM, Valone FH, Memoli VA, Bzik DJ, Yao S -LJCe, biomarkers, prevention: a publication of the American association for cancer research CbtASoPO (1994) soluble normal and mutated DNA sequences from single-copy genes in human blood. 3:67\u201371"},{"key":"2349_CR56","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1159\/000226740","volume":"46","author":"M Stroun","year":"1989","unstructured":"Stroun M, Anker P, Maurice P, Lyautey J, Lederrey C, Beljanski MJO (1989) Neoplastic characteristics of the DNA found in the plasma of cancer patients. Oncology 46:318\u2013322","journal-title":"Oncology"},{"key":"2349_CR57","first-page":"2475","volume":"40","author":"A Szakal","year":"1980","unstructured":"Szakal A, Diwan B, Blackman KJCR (1980) Modulation of immunological competence in 1, 2-dimethylhydrazinesensitive SWR\/J mice during colorectal carcinogenesis. Cancer Res 40:2475\u20132485","journal-title":"Cancer Res"},{"key":"2349_CR58","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, Gable AL, Fang T, Doncheva NT, Pyysalo SJN (2023) The STRING database in 2023: protein\u2013protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucl Acids Res 51:D638\u2013D646","journal-title":"\u00a0Nucl Acids Res"},{"key":"2349_CR59","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1172\/JCI105479","volume":"45","author":"E Tan","year":"1966","unstructured":"Tan E, Schur P, Carr R, Kunkel HJ (1966) Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus. J Clin Invest 45:1732\u20131740","journal-title":"J Clin Invest"},{"key":"2349_CR60","doi-asserted-by":"publisher","first-page":"109821","DOI":"10.1016\/j.biopha.2020.109821","volume":"124","author":"S Tan","year":"2020","unstructured":"Tan S, Li D, Zhu XJB (2020) Cancer immunotherapy: Pros, cons and beyond. Pharmacotherapy 124:109821","journal-title":"Pharmacotherapy"},{"key":"2349_CR61","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00239-023-10092-6","volume":"91","author":"DD Trivedi","year":"2023","unstructured":"Trivedi DD, Dalai SK, Bakshi SR (2023) The mystery of cancer resistance: A revelation within nature. J Mol Evol 91:133\u2013155","journal-title":"\u00a0J Mol Evol"},{"key":"2349_CR62","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","volume":"575","author":"N Vasan","year":"2019","unstructured":"Vasan N, Baselga J, Hyman DM (2019) A view on drug resistance in cancer. Nature 575:299\u2013309","journal-title":"Nature"},{"key":"2349_CR63","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1111\/j.1365-2141.1994.tb04828.x","volume":"86","author":"V Vasioukhin","year":"1994","unstructured":"Vasioukhin V, Anker P, Maurice P, Lyautey J, Lederrey C, Stroun MJB (1994) Point mutations of the N-ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia. Brit J Haematol 86:774\u2013779","journal-title":"Brit J Haematol"},{"key":"2349_CR64","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1056\/NEJMp1508811","volume":"373","author":"B Vogelstein","year":"2015","unstructured":"Vogelstein B, Kinzler KW (2015) The path to cancer\u2014three strikes and you\u2019re out. New Eng J Med 373:1895\u20131898","journal-title":"New Eng J Med"},{"key":"2349_CR65","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1158\/1541-7786.MCR-16-0044","volume":"14","author":"S Volik","year":"2016","unstructured":"Volik S, Alcaide M, Morin RD, Collins CJMCR (2016) Cell-free DNA (cfDNA): clinical significance and utility in cancer shaped by emerging technologies. Mol Cancer Res 14:898\u2013908","journal-title":"Mol Cancer Res"},{"key":"2349_CR66","first-page":"71","volume":"59","author":"IH Wong","year":"1999","unstructured":"Wong IH, Dennis Lo Y, Zhang J, Liew C-T, Ng MH, Wong N, Lai PB, Lau WY, Hjelm NM, Johnson PJJC (1999) Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients. Cancer Res 59:71\u201373","journal-title":"Cancer Res"},{"key":"2349_CR67","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12943-023-01801-2","volume":"22","author":"Y Wu","year":"2023","unstructured":"Wu Y, Song Y, Wang R, Wang T (2023) Molecular mechanisms of tumor resistance to radiotherapy. Mol Cancer 22:96","journal-title":"Mol Cancer"},{"key":"2349_CR68","first-page":"31","volume":"63","author":"M-AI Zamfir","year":"2022","unstructured":"Zamfir M-AI, Buburuzan L, Hudi\u0163\u0103 A, G\u0103l\u0103\u0163eanu B, Ginghin\u0103 O, Ion D, Mota\u015f N, Ardeleanu CM (2022) Liquid biopsy in lung cancer management. Costache MJRJoM Embryol 63:31","journal-title":"Costache MJRJoM Embryol"},{"key":"2349_CR69","doi-asserted-by":"crossref","unstructured":"Zanzonico, PJSaib (2017) guide p Noninvasive imaging for supporting basic research.3\u201332","DOI":"10.1007\/978-3-319-42202-2_1"},{"key":"2349_CR70","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","volume":"17","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Zhang ZJC (2020) The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications. Cellular Mol Immunol 17:807\u2013821","journal-title":"Cellular Mol Immunol"},{"key":"2349_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-023-01433-5","volume":"16","author":"Z Zhu","year":"2023","unstructured":"Zhu Z, Hu E, Shen H, Tan J, Zeng SJJH (2023) The functional and clinical roles of liquid biopsy in patient-derived models. J Hematol Oncol 16:1\u201317","journal-title":"J Hematol Oncol"}],"container-title":["Molecular Genetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00438-026-02349-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00438-026-02349-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00438-026-02349-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T10:02:29Z","timestamp":1769853749000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00438-026-02349-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,31]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["2349"],"URL":"https:\/\/doi.org\/10.1007\/s00438-026-02349-8","relation":{},"ISSN":["1617-4615","1617-4623"],"issn-type":[{"value":"1617-4615","type":"print"},{"value":"1617-4623","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,31]]},"assertion":[{"value":"26 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"29"}}